|
|
Volumn 39, Issue 10, 2000, Pages 1055-1057
|
|
Male osteoporosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
25 HYDROXYVITAMIN D;
ALCOHOL;
ALENDRONIC ACID;
ANABOLIC AGENT;
ANDROGEN;
ANTICONVULSIVE AGENT;
AROMATASE;
BISPHOSPHONIC ACID DERIVATIVE;
CALCIUM;
COLECALCIFEROL;
ESTRADIOL;
ESTROGEN RECEPTOR;
ETIDRONIC ACID;
FLUOROPHOSPHATE;
GONADOTROPIN;
GROWTH HORMONE;
NANDROLONE;
PARATHYROID HORMONE;
PROSTATE SPECIFIC ANTIGEN;
SEX HORMONE BINDING GLOBULIN;
SOMATOMEDIN C;
STEROID;
TESTOSTERONE;
VITAMIN D;
BACKACHE;
BODY HEIGHT;
BONE ATROPHY;
BONE DENSITY;
BONE INJURY;
BONE MASS;
BONE MINERAL;
BONE TURNOVER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST;
DRUG USE;
DUAL ENERGY X RAY ABSORPTIOMETRY;
EDITORIAL;
EMOTION;
ENERGY;
FEMALE;
GENDER;
GENE MUTATION;
HIP FRACTURE;
HUMAN;
HYPERPARATHYROIDISM;
HYPERTHYROIDISM;
HYPOGONADISM;
KYPHOSIS;
MALE;
MORBIDITY;
MORTALITY;
OSTEOPOROSIS;
PRIORITY JOURNAL;
RISK FACTOR;
SLEEP DISORDER;
SMOKING;
STEROID THERAPY;
SUPPLEMENTATION;
SYMPTOMATOLOGY;
VERTEBRA FRACTURE;
|
|
EID: 0033790569
PISSN: 14620324
EISSN: None
Source Type: Journal
DOI: 10.1093/rheumatology/39.10.1055 Document Type: Editorial |
|
Times cited : (15)
|
|
References (20)
|
